The webinar will feature presentations by Key Opinion Leaders (KOLs)

Anne L. Peters, MD (Keck School of Medicine of USC) and Alexander Fleming, MD (Formerly with the FDA and currently The Kitalys Institute), who will discuss the current treatment landscape, the unmet medical need, and the potential for ORMD-0801, an oral insulin candidate currently in phase 3 trials, in treating patients with Type 2 diabetes.

A live question and answer session will follow which will include members of the Oramed management team.